Kinofta

Levofloxacin, the active ingredient in Kinofta, is a fluoroquinolone presented as an ophthalmic preparation for ocular use. It treats bacterial eye infections, including conjunctivitis and keratitis, in patients requiring topical antibiotic therapy.

GNH USA supplies Kinofta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for qualified healthcare providers.

Kinofta, containing levofloxacin, is employed in the management of bacterial ocular infections.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Post‑operative ocular prophylaxis: prevents infection after eye surgery such as cataract extraction. - Contact lens‑related infections: treats bacterial contamination associated with lens wear.

Ocular administration of levofloxacin may be associated with a range of local and systemic adverse reactions.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Redness: transient conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Allergic reaction: swelling, itching, or rash around the eye. - Corneal ulceration: worsening of corneal integrity. - Stevens‑Johnson syndrome: severe mucocutaneous reaction. - Vision loss: sudden decrease in visual acuity. - Severe ocular inflammation: uveitis or endophthalmitis.

Before using Kinofta, consider the following precautions to ensure safe and effective therapy. - Allergy assessment: avoid use in patients with known hypersensitivity to fluoroquinolones. - Corneal integrity: do not use on compromised corneal epithelium without medical supervision. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Systemic absorption: monitor for systemic fluoroquinolone effects in children and the elderly. - Pregnancy and lactation: use only if the potential benefit outweighs the unknown risk. - Store at room temperature: keep in the original container, protect from moisture and light.

Levofloxacin may interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use can increase risk of systemic toxicity. - Antacids containing magnesium or aluminum: may reduce ocular absorption if administered simultaneously. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: combined use may heighten risk of corneal perforation. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): monitor for delayed wound healing. - Diabetes medications: observe for potential alterations in glycemic control.